https://www.avient.com/sites/default/files/2023-11/SEM TPE Product Selector Guide _N. America only_2023.pdf
FEATURED TPES FOR CONSUMER APPLICATIONS
CO
N
SU
M
ER
GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES
Appearance Hardness Specific Gravity
Food
Contact UL 94
Suitable
Substrates Injection Extrusion
ASTM
Shore
ASTM
(D792)
Consumer Electronics Series
Versaflex™ CE 3120-40 Natural 42A 0.92 - -
PC, ABS, PC/ABS,
COPE ✔
-
Good compression set—ideal for
device cases or electronic grips
Versaflex™ CE 3120-65 Natural 66A 1.15 - HB
PC, ABS, PC/ABS,
COPE ✔
-
Chemical and abrasion resistant; 4.69 cradle-to-gate
PCF—ideal for device cases or electronic grips
Versaflex™ CE 3140-65N Natural 65A 1.00 - -
PC, ABS, PC/ABS,
COPE ✔
-
5G transparent materials—ideal for
device cases or gaskets
Versaflex™ CE 3140-90N Natural 90A 1.01 - -
PC, ABS, PC/ABS,
COPE ✔
-
5G transparent materials—ideal for
device cases or gaskets
Versaflex™ CE 3620
Black/
Natural
65A 1.00 - HB
PC, ABS, PC/ABS,
COPE ✔
-
Chemical and abrasion resistant, hydrolitically
stable—ideal for electronic grips/gaskets or wearables
Engineering Resin Overmolds
Versaflex™ OM 1060X-1 Natural 60A 0.93 ✔ - PC, ABS, PC/ABS ✔ - Versatile OM resin—ideal for grips/gaskets
Versaflex™ OM 9-801N Natural 47A 1.04 ✔ HB
PC, ABS, PC/ABS,
PPO, POM, COPE,
PMMA, HIPS
✔ - Soft touch/rubber feel—ideal for grips/gaskets
Versaflex™ OM 9-802CL Clear 40A 0.92 ✔ -
PC, ABS, PC/ABS,
COPE ✔
- Soft touch/rubber feel—ideal for grips/gaskets
Versaflex™ OM 6059-9 Black 58A 1.10 - HB PA 6 and 6,6 ✔ -
Superior adhesion—ideal for grips,
power tools/equipment
Versaflex™ OM 6160-1
Black/
Natural
60A 1.11 ✔ HB PA 6 and 6,6 ✔
Superior adhesion—ideal for grips,
power tools/equipment
Versaflex™ OM 6240-1 Natural 43A 1.09 - - PA 6 and 6,6 ✔ -
Superior adhesion — ideal for grips,
power tools/equipment
Versaflex™ OM 6258-1 Natural 62A 1.09 - - PA 6 and 6,6 ✔ -
Superior adhesion—ideal for grips,
power tools/equipment
Versaflex™ OM 6258-9 Black 62A 1.09 - HB PA 6 and 6,6 ✔ -
Superior adhesion—ideal for grips,
power tools/equipment
Versaflex™ OM 6275-9 Black 75A 1.10 - - PA 6 and 6,6 ✔ -
Superior adhesion—ideal for grips,
power tools/equipment
Versollan™ OM1255NX Black 59A 1.05 - HB
PC, ABS, PC/ABS,
PC/PBT, COPE ✔
- Superior adhesion—ideal for power tool grips
Versollan™ RU 2205-1 Natural 65A 1.16 - HB
PC, ABS, PC/ABS,
COPE ✔ ✔
High performance, rubber feel
GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES
Appearance Hardness Specific Gravity
Food
Contact UL 94
Suitable
Substrates Injection Extrusion
ASTM
Shore
ASTM
(D792)
Special Series
Versaflex™ VDT 4202-40B Black 40A 1.00 - - PP ✔ ✔
Vibration dispersion—ideal for washer/dryer
feet or shin guards
Versaflex™ G2800-17 Pink 18 OO 0.85 - - - ✔ - Skin-like feel—ideal for adult toys
Versaflex™ SP 2820-55N Natural 55A 0.91 ✔ - - ✔ ✔ Superior puncture and tear resistance—ideal for dog toys
Versaflex™ XP 2850 Natural 55A 0.88 ✔ - - ✔ ✔ Wet grip—ideal for water sports or grips
Versaflex™ GP 2810-40N AM US Translucent 45A 0.87 ✔ - - ✔ - Antimicrobial
Versaflex™ CE 3120-65 AM Natural 67A 1.15 - -
PC, ABS, PC/ABS,
COPE ✔
- Antimicrobial for consumer electronics
Versalloy™ XL 9045-1 Natural 44A 0.88 ✔ - - ✔ -
Excellent flow for long, thin flow paths—
ideal for grips or thin wall parts
Versalloy™ XL 9055-1 Natural 53A 0.89 ✔ - PP ✔ -
Excellent flow for long, thin flow paths—
ideal for grips or thin wall parts
Versalloy™ XL 9055X-9 Black 53A 0.89 ✔ HB PP ✔ -
Excellent flow for long, thin flow paths—
ideal for grips or thin wall parts
Versalloy™ XL 9070-1 Natural 70A 0.89 ✔ - PP ✔ -
Excellent flow for long, thin flow paths—
ideal for grips or thin wall parts
Versalloy™ XL 9070X-9 Black 70A 0.89 ✔ HB PP ✔ -
Excellent flow for long, thin flow paths;
2.54 cradle-to-gate PCF—ideal for grips or thin wall parts
Dynaflex™ G7702-9001-02 Black 37A 1.10 - - PP ✔ ✔ High temperature performance—ideal for seals and gaskets
Dynalloy™ DT 7910W White 45A 0.93 ✔ - - ✔ ✔ Low compression—ideal for dairy tubing
Versaflex™ CL 2000X Clear 3A 0.87 ✔ - - ✔ ✔ Ultra soft
Versaflex™ CL 2003X Clear 33 OO 0.87 ✔ - - ✔ ✔ Gel feel
Versaflex™ CL30 Clear 30A 0.89 ✔ - PP ✔ ✔ High clarity, high tackiness
Versaflex™ CL40 Clear 43A 0.89 ✔ HB - ✔ ✔ High clarity, high tackiness
General Purpose Series
Versaflex™ GP 2810 Translucent 20A–60A 0.88 ✔ - - ✔ ✔ Unfilled
Versaflex™ GP 2810 Translucent 70A–90A 0.89 ✔ HB - ✔ ✔ Unfilled
Dynaflex™ G7920 Natural/Black 20A 1.01 ✔ - PP ✔ ✔ Filled
Dynaflex™ G7900 Natural/Black 30A–90A 1.05–1.20 ✔ HB PP ✔ ✔ Filled
FEATURED TPES FOR CONSUMER APPLICATIONS
CO
N
SU
M
ER
GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES
Appearance Hardness Specific Gravity
Compression Set
@ 23°C
Compression Set
@ 100°C
Food
Contact
ISO
10993 USP VI UL 94
Suitable
Substrates
Injection Extrusion
ASTM
Shore A
ASTM
(D792) ASTM % ASTM %
Tubing
Versaflex™ G2705 N Translucent 60 0.89 20 - ✔ ✔ ✔ ✔ PP ✔ ✔
High resiliance, low compression set, and good puncture
sealing–ideal for medical and biopharma tubing
Versaflex™ HC BT218 Translucent 67 0.89 19 69 - ✔ ✔ ✔ - - ✔ Weldable and kink resistant—ideal for biopharma tubing
Versalfex™ HC BIO BT218 Translucent 70 0.88 18 58 - ✔ ✔ - - - ✔
Weldable and kink resistant; 40% bio-derived content
(Gen 1 biomass)—ideal for biopharma tubing
Versaflex™ HC MT317 Translucent 68 0.89 17 69 - ✔ ✔ ✔ - - ✔
Flexible and kink resistant, high service temperature
—ideal for medical and biopharma tubing
Versalloy™ HC 9220-70 Natural 70 0.95 17 51 - ✔ ✔ - PP ✔ ✔
High temperature resistance—ideal for
peristaltic pump tubing
Syringe Components
Versaflex™ HC 2110-35N Natural 35 0.89 19 47 - ✔ ✔ - LDPE, PP ✔ -
Good puncture sealing and elevated temperature
performance—ideal for septums
Versaflex™ HC 2110-57B Black 57 1.01 20 37 - ✔ ✔ - - ✔ -
Low coefficient of friction and elevated temperature
performance—ideal for plungers and stoppers
Engineering Resin Overmolds
Versaflex™ OM 1040X-1 Translucent 42 0.92 22 - ✔ ✔ ✔ - PC, ABS, PC/ABS ✔ -
Good compression set at room temperature—
ideal for seals and grips
Versaflex™ OM 3060-1 Clear 59 0.90 33 - ✔ ✔ ✔ HB
PC, ABS, PC/ABS,
PC/PETG, PC/PBT ✔
-
Good compression set at room temperature
and UV stability—ideal for seals and grips
Versaflex™ OM 8940X-1 Clear 40 0.92 20 - ✔ ✔ - -
PK, COPE, PC, ABS,
PC/ABS ✔
-
Excellent chemical resistance to alcohols and
disenfectants—ideal for grips on medical devices
Versaflex™ OM 4052 Translucent 56 1.01 27 - ✔ - - - PC, ABS, PC/ABS ✔ -
Excellent chemical resistance to skin oils,
like sebum, and hand lotion—ideal for
consumer healthcare applications
Versaflex™ OM 4063 Translucent 64 1.12 30 - ✔ - - PC, ABS, PC/ABS ✔ -
Excellent chemical resistance to skin oils,
like sebum, and hand lotion—ideal for
consumer healthcare applications
General Purpose Applications
Versaflex™ CL E85 Clear 85 0.90 20 72 ✔ ✔ ✔ - - - ✔ High clarity without plasticizers—ideal for extrusion
Versaflex™ HC 3810 Series Translucent 20–90 0.88 16 54 - ✔ - - - ✔ -
Formulated without animal derivatives,
excellent colorability—ideal for seals and labware
Versaflex™ G2705 N Translucent 60 0.89 20 - ✔ ✔ ✔ - PP ✔ ✔
High resiliance, low compression set,
and good puncture sealing
Versalloy™ HC 9220-70 Natural 70 0.95 17 51 - ✔ - - PP ✔ ✔ High temperature resistance
Versalloy™ HC 9210 Series Natural 55 & 70 0.89 20 44 - - ✔ - - ✔ -
Formulated without animal derivatives—
ideal for injection molding long thin flow paths,
smooth surface aesthetics
Versaflex™ CL2242 Clear 43 0.89 23 - ✔ ✔ ✔ - - ✔ - High clarity maintained after boiling cleaning processes
Versaflex™ CL2250 Clear 50 0.89 20 - ✔ ✔ ✔ - - ✔ - High clarity maintained after boiling cleaning processes
FEATURED TPES FOR HEALTHCARE APPLICATIONS
H
EALTH
CAR
E
GENERAL PROPERTIES REGULATORY BONDING PROCESS FEATURES
Appearance Hardness Specific Gravity Weatherability* VOC FOG Odor** UL 94
Suitable
Substrates Injection Extrusion
ASTM
Shore A
ASTM
(D792)
Internal QUV
1000hrs (Delta E)
VDA 278
μg/g (ppm)
VDA 278
μg/g (ppm)
Recycled Content Series
reSound™ REC OF 7310-80
Black/
Natural (Gray)
80 0.90 0.35 75 379 3 (VDA 270) - PP ✔
35% PCR/PIR content (food packaging)—
ideal for automotive interior applications
reSound™ REC OF 7310-90
Black/
Natural (Gray)
90 0.91 0.11 160 557 3 (VDA 270) - PP ✔
45% PCR/PIR content (food packaging)—
ideal for automotive interior applications
General Purpose Series
OnFlex™ G7705 B Black 42 1.20 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications
OnFlex™ G7705 N Natural 44 1.18 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications
OnFlex™ G7720 B Black 57 1.16 0.55 - - - HB PP ✔ ✔ Easy processing for a wide variety of applications
OnFlex™ G7720 N Natural 55 1.17 3.72 - - - HB PP ✔ ✔ Easy processing for a wide variety of applications
OnFlex™ G7820 N Natural 92 1.14 - - - - - PP ✔ ✔ Easy processing for a wide variety of applications
Automotive Fasteners & Interior Components
OnFlex™ AF 7210 Series Natural 40–90 1.00 - - - - - PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 40 1.00 0.49 113 845
2 (SAE J1351,
Dry)
- PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 50 1.00 0.42 51 762
2 (SAE J1351,
Dry)
- PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 60 1.00 0.21 112 1740
1 (SAE J1351,
Dry)
- PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 70 0.99 0.22 105 1976
3 (SAE J1351,
Dry)
- PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 80 1.00 0.32 74 4459
3 (SAE J1351,
Dry)
- PP ✔ - Low odor and good UV resistance
OnFlex™ AF 7210 Black 90 1.00 - - - - - PP ✔ - Low odor and good UV resistance
HVAC & Interior Components
OnFlex™ LO 7120-45N Natural 45 1.15 3.21 41 521
2 (SAE J1351,
Dry)
- PP ✔ -
Significant reductions in VOCs and fogging
compared to traditional TPE technologies
GLS™ TPEs with Antimicrobial Technologies
OnFlex™ LO 7120-45B AM Black 45 1.13 0.52 - - - - PP ✔ - Imbedded antimicrobial technology
FEATURED TPES FOR TRANSPORTATION APPLICATIONS
TRAN
SPO
RTATIO
N * Values were taken on 3mm plaques following 1000hrs of continious exposure to UVA-340
** Samples were conditioned at 23C at 35% RH for 24 hrs.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
16
2 0 2 1 O U T L O O K
Synergies
($ millions)
Initial
Three-Year
Estimate
Revised
Three-Year
Estimate
2021
Expected
Realization
Administrative $ 18 $ 20 $ 15
Sourcing 24 30 15
Operational 18 25 5
Total Synergies $ 60 $ 75 $ 35
C L A R I A N T I N T E G R AT I O N &
C O S T S Y N ERG I E S U PDATE
18
• Integration going extremely well: synergy target increased from $60 million to $75 million
• $5 million of synergies in 2020 and expect to realize $35 million in 2021
• Relentless focus on guiding principles of safety first, employee collaboration and exceeding
customer expectations
• Future revenue synergies are not part of these estimates and represent additional growth over
the long term
$86
$103
2020PF 2021E
$0.53
$0.70
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q1
( T O TA L C O M PA N Y )
19
Sales Adjusted Operating Income
$991
$1,090
2020PF 2021E
+ 10%
Adjusted EPS
+ 20% + 32%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
$308
$360
2020PF 2021E
$1.93
$2.40
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – FULL YEAR
( T O TA L C O M PA N Y )
20
Sales Adjusted Operating Income
$3,783
$4,100
2020PF 2021E
+ 8%
Adjusted EPS
+ 17% + 24%
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(1) (1)
(in millions) (in millions)
(1)
2020 Pro forma $3,783 $308
Sustainable Solutions 60 11% 24
Healthcare 60 11% 18
Composites 20 10% 10
Growth in Emerging Regions 50 7% 11
Other (GDP growth) 82 5% 11
Sub-total $4,055 7% $382
COVID Response Applications (25) - (11)
Outdoor High Performance Applications (15) - (7)
Asia Payroll Tax Subsidy (COVID) - - (4)
FX Impact 85 - 7
Synergies - - 30
Incentives, Travel, Other Employee Costs - - (37)
2021 Estimated $4,100 8% $360
2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
21
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) COVID Response Applications: facemasks, personal protective equipment
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
(2)
C A S H F LOW A N D L E V E R AGE
22
• Asset light business generates
significant free cash flow
• Cash generation in 2021 partially offset
by restructuring activities to capture
synergies associated with the Clariant
Masterbatch acquisition
• Cash flow deployed to M&A,
opportunistic share repurchases and
balance sheet / leverage reduction
3.5x
2.7x
2.1x
2019PF 2020PF 2021E
Net Debt / Adjusted EBITDA
(1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
($ millions) 2020 2021E
Adjusted EBITDA 382 510
Working Capital: Source / (Use) 116 (30)
Cash Taxes (40) (53)
Interest Paid (67) (76)
CapEx (62) (75)
CapEx for Synergy Capture (2) (20)
Restructuring for Synergy Capture (11) (25)
Other 22 19
Free Cash Flow 338 250
23
• 8% increase in sales drives 24% increase in adjusted EPS to $2.40
($2.70 excluding step-up depreciation and amortization) as a result of
continued growth in sustainable solutions and synergy capture
• Clariant synergy capture ahead of schedule: $35M of savings planned from
Clariant Masterbatch acquisition
• Adjusted EBITDA of $510M – highest level in company history
• Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the
end of 2021
2021 PROJECTIONS
PEER COMPARISONS
24
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
10
2 0 2 1 O U T L O O K
Synergies
($ millions)
Initial
Three-Year
Estimate
Revised
Three-Year
Estimate
2021
Expected
Realization
Administrative $ 18 $ 20 $ 15
Sourcing 24 30 15
Operational 18 25 5
Total Synergies $ 60 $ 75 $ 35
C L A R I A N T I N T E G R AT I O N &
C O S T S Y N ERG I E S U PDATE
12
• Integration going extremely well: synergy target increased from $60 million to $75 million
• $5 million of synergies in 2020 and expect to realize $35 million in 2021
• Relentless focus on guiding principles of safety first, employee collaboration and exceeding
customer expectations
• Future revenue synergies are not part of these estimates and represent additional growth over
the long term
$86
$103
2020PF 2021E
$0.53
$0.70
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q1
( T O TA L C O M PA N Y )
13
Sales Adjusted Operating Income
$991
$1,090
2020PF 2021E
+ 10%
Adjusted EPS
+ 20% + 32%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
$308
$360
2020PF 2021E
$1.93
$2.40
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – FULL YEAR
( T O TA L C O M PA N Y )
14
Sales Adjusted Operating Income
$3,783
$4,100
2020PF 2021E
+ 8%
Adjusted EPS
+ 17% + 24%
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(1) (1)
(in millions) (in millions)
(1)
2020 Pro forma $3,783 $308
Sustainable Solutions 60 11% 24
Healthcare 60 11% 18
Composites 20 10% 10
Growth in Emerging Regions 50 7% 11
Other (GDP growth) 82 5% 11
Sub-total $4,055 7% $382
COVID Response Applications (25) - (11)
Outdoor High Performance Applications (15) - (7)
Asia Payroll Tax Subsidy (COVID) - - (4)
FX Impact 85 - 7
Synergies - - 30
Incentives, Travel, Other Employee Costs - - (37)
2021 Estimated $4,100 8% $360
2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
15
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) COVID Response Applications: facemasks, personal protective equipment
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
(2)
C A S H F LOW A N D L E V E R AGE
16
• Asset light business generates
significant free cash flow
• Cash generation in 2021 partially offset
by restructuring activities to capture
synergies associated with the Clariant
Masterbatch acquisition
• Cash flow deployed to M&A,
opportunistic share repurchases and
balance sheet / leverage reduction
3.5x
2.7x
2.1x
2019PF 2020PF 2021E
Net Debt / Adjusted EBITDA
(1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
($ millions) 2020 2021E
Adjusted EBITDA 382 510
Working Capital: Source / (Use) 116 (30)
Cash Taxes (40) (53)
Interest Paid (67) (76)
CapEx (62) (75)
CapEx for Synergy Capture (2) (20)
Restructuring for Synergy Capture (11) (25)
Other 22 19
Free Cash Flow 338 250
We sell solutions not commodities.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Global%2520Engineered%2520Materials.pdf
Nikrant
Page 67
United
States
36%
Europe
36%
Canada
2%
Asia
20%
Latin
America
2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions
At a Glance
Global Specialty Engineered Materials
Appliance
6% Building &
Construction
3%
Wire & Cable
14%
Electrical &
Electronics
14%Consumer
21%
Packaging
5%
Industrial
8%
Misc.
3%
HealthCare
5%
Transportation
21%
America
6%
2011 Revenue by Industry Segment2011 Revenue by Industry Segment
1.1%
1.3%
3.4%
5.1%
9.6%
8.0%
12-16%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
Target
Expanding ProfitsExpanding Profits
Page 68
Value Proposition
• GSEM is a global leader providing complete specialty solutions encompassing
innovative technologies and services to enable customer success
Transformation Highlights
• Dramatic turnaround of the Engineered Materials business through mix
improvement and specialty focus
Value Proposition and Transformation Highlights
Global Specialty Engineered Materials
improvement and specialty focus
• GLS acquisition successfully integrated, having more than
doubled earnings in 3 years
• PolyOne culture and strategy now engrained worldwide
• Expansion into healthcare with dedicated resources
> $15B Addressable Market
Page 69
• Polymer design, formulation and service expertise
• Broad, global technology base and regional centers
of excellence
• Ten innovation centers around the world
Key Differentiators
Global Specialty Engineered Materials
• Ten innovation centers around the world
• Specialty brand leadership with
PolyOne, GLS, NEU and ECCOH
• Ability to leverage global key
account team
Page 70
From Volume
Commodity-driven product portfolio
To Value
Specialty technology and solutions
EM North America Transformation
Volume Sales Gross Margin $
Mix Transformation – Executing the Strategy
Global Specialty Engineered Materials
2006 2011 2006 2011 2006 2011
Page 71
$12
$29
Operating Income
($ in millions)
• Provided access to new customers
in specialized, high-growth markets
such as healthcare and consumer
• Strategic partner to many of the
world’s best-known companies
GLS Integration Success
16.9%
8.2%
2007 2011
2007 2011
Working Capital % of Sales
• Complementary global footprint
provided additional cross-selling
opportunities
• Opportunity to expand margins
and drive working capital
improvement while remaining
customer-focused
Page 72
$1.3
$27.6
2006 2011
Healthcare Revenue
• Investment in dedicated
healthcare team to drive
penetration and growth
• Leverage product portfolio
globally & win specialty business
Areas of Focus
Global Specialty Engineered Materials
$10.5
$117.9
2006 2011
Consumer Revenue
2006 2011globally & win specialty business
in targeted markets
• Aggressively commercialize
specialty innovation platforms
• Utilize our innovation centers to
influence OEM design
(Revenue in $ millions)
Page 73
• Carbon Nanotube Formulations
� Applications: Semiconductor equipment, hard drives
� Customer benefits: Scrap cost reduction and
clean conductivity
• Thermally Conductive Solutions
Applications: Sockets and bulb holders for LED lighting
Key Innovations
Global Specialty Engineered Materials
� Applications: Sockets and bulb holders for LED lighting
� Customer benefits: Cost reduction, energy saving, and
design flexibility
• FDA-Regulated TPEs
� Applications: Food packaging seals, intravenous delivery
systems, medical stoppers, prefilled syringes
� Customer benefits: Clean and safe elastomers for highly
regulated applications
Page 74
Critical Imperatives and 2015 Goal
Global Specialty Engineered Materials
Critical Imperatives
• Commercialize critical new technology platforms
• Manage the mix as we continue to drive
the transformation
• Global translation of commercial successes
2015 Goal
• 12 - 16% return on sales
Page 75
Page 76
https://www.avient.com/sites/default/files/2021-03/colorant-chromatics-high-temp-compounds-selection-guide.pdf
KEY FEATURES
• High temperature resistance
• Biocompatible
• Brilliant colors
• Multi sterilizable
• Hydrolytic stability
• Chemical resistance
• Flame resistance
• High mechanical performance
• Food contact compliant
APPLICATIONS
• FDA medical & dental devices
• Sterilization trays
• Aircraft interiors
• Automotive lighting
• Chemical handling
• Sensors and pumps
• Plumbing fittings & manifolds
• Food service trays
• Gears & bushings
• Membranes
• Connectors
For more information, email
info.colorant.chromatics@avient.com
or call +1.860.626.3029
1.844.4AVIENT
www.avient.com
Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/2023-09/Avient Sustainability Day 2023 - Website %289.19%29.pdf
CAFE: Corporate Average Fuel Economy
>50% Improvement
REDUCE – TAKEAWAY
Reducing Energy Consumption and Dependence on Fossil Fuels Drives Growth Projections
Examples
Covered
Today
45%
Other
Applications
55%
2022PF
$310M
38
46
CAFE1 Miles Per Gallon Proposed Requirements
HOW WE ENABLE SUSTAINABILITY
Preserve
Woon Keat Moh
Senior Vice President, President of Color, Additives and Inks –
Americas and Asia
Avient Corporation 61
PRESERVE
Avient Corporation 62
KEY CUSTOMER CHALLENGES:
• Preserving Key Natural Resources - Companies are being challenged to
mitigate high environmental impact processes such as water-intensive textile dyeing or
food spoilage
• Incorporating Renewable Materials - Adoption of bio-based raw materials
requires design and formulation expertise to overcome performance shortcomings of
neat resins
• Increasing Healthcare Regulations - Utilizing sustainable materials in
healthcare applications requires considerable support in navigating complex regulatory
requirements
• Increasing Regulatory Compliance - Non-Intentionally Added Substances
(NIAS) need to be controlled in sensitive applications
• Enabling Faster and More Reliable Connectivity – Substantial investments
in 5G infrastructure are required to unlock the potential of the Internet of Things
Solutions to preserve and
protect natural resources &
human life
Avient Corporation 63
Spin Dyed Precolor Textile Yarn
Renol™ Spin Dyeing Colorants
• Replaces water-based dye processes to reduce
waste creation
• Conserves water and energy
75%
LESS WATER
PROTECTIVE DENIM
Dyneema® Workwear Solutions
• Improves tear resistance 50-100%
• More protective than competitive alternatives
• Enables the amount of protective fiber to be
reduced without sacrificing performance
600%
IMPROVED ABRASION RESISTANCE
Clothing & Textiles
2022 Revenue: $49M
Avient Corporation 64
Low Cure Textile Inks
Avient Specialty Inks™ Low Cure Inks
• Decreases energy consumption
• Reduces scrap due to heat-related defects
SAVES ENERGY
Clothing & Textiles
2022 Revenue: $40M
BIO-BASED
FORMULATIONS
Water Based Textile Inks
Zodiac™ Aquarius™ Specialty Inks
• Incorporates bio-based materials
• Non-formaldehyde solutions available
• Reduces waste by enabling high open screen time
Avient Corporation 65
Mosquito Netting
Cesa™ Fiber Anti-Mosquito Additives
• Helps control malaria
• Protects consistently using a controlled
release of insecticide
• Expands access to healthcare
breakthroughs to global communities
ANNUAL NEW MALARIA CASES
200 Million
Antimicrobial Protection
Cesa™ WithStand™ Antimicrobial Additives
• Reduces microbial / mold growth
• Helps reduce odor, staining, discoloration
• Excellent comfort and wearability
• Chemical resistance - will not discolor
or degrade
REDUCES MICROBES
Human Health & Safety
2022 Revenue: $5M
Avient Corporation 66
Cut-Resistant Gloves
Dyneema® Solutions
• Incorporates bio-based materials
• Reduces carbon emissions
• Excellent wearability / comfort
WORK INJURIES
REDUCES
Rescue Rope
Dyneema® Solutions
• Superior strength-to-weight ratio
• High break load
• Extraordinary reliability
SAVES LIVES
Human Health & Safety
2022 Revenue: $106M
Body Armor
Dyneema® Protective Solutions
• Exceptional trauma protection
• Excellent wearability
LIGHTER
THAN ARAMID FIBER
35%
Avient Corporation 67
40%
BIO-DERIVED
Pharmaceutical Tubing
Versaflex™ Healthcare Pharma Tubing Formulations
NEU™ Specialty Engineered Materials
• Facilitates incorporation of sustainable materials
with healthcare device manufacturers
• Eliminates vulcanization processes
Medical
2022 Revenue: $40M
NON-PHTHALATE
Respiratory Conduit
Versaflex™ Healthcare Corrugated
Tubing Formulations
• Non-Phthalate
• ISO 10993 & USP Class VI compliant
Avient Corporation 68
100%
UP TO
BIO-BASED CARRIER
Medical Devices
Mevopur™ Bio-Based Colorants
• Minimizes risk through pre-testing
• Provides vital regulatory compliance
• Minimizes global supply chain risk with
validated backup supply
Continuous Glucose Monitoring
and Auto Injectors
Trilliant™ Healthcare Polymer Solutions
• Impact performance
• Chemical resistance
ENABLES HOME CARE
Medical
2022 Revenue: $16M
Avient Corporation 69
Fiber Optic Cable and Jacketing
Fiber-Line™ Optical Fiber Cable Components
• Reduction in weight & energy usage
• Thermal and abrasion resistant
• Extends product life
ENABLES CONNECTIVITY
Cable Micromodules
ECCOH™ Low Smoke Formulations
• Non-halogen
• Low smoke and toxicity
SUPPORTS SUSTAINABLE
INFRASTRUCTURE
Base Station Components
Edgetek™ Low-Density Formulations
• Low density – lighter weight
• Low warpage & thermal conductivity
EXTENDS PRODUCT LIFE
Antenna Components
PREPERM™ Low Loss
Dielectric Formulations
• Replaces costly ceramics
• Consistent and efficient antenna performance
ENHANCES
PERFORMANCE
5G Infrastructure
2022 Revenue: $39M
Avient Corporation 70
“Nike has partnered with Avient extensively over the years because of their leadership in
eco-friendly screen printing inks.”
Per Carlsson, Manufacturing and Operations
CUSTOMER
TESTIMONIALS
Avient Corporation 71
50
90
0
20
40
60
80
100
2022 2030
Medical Plastics Market Size
PRESERVE – TAKEAWAY
Protecting Human Life and Enabling Connectivity Drives Growth Projections
Examples
Covered
Today
56%
Other Applications
44%
2022
$525M (i
n
$B
ill
io
ns
)
8% CAGR 34% CAGR
5G Infrastructure Market Size
12
92
0
10
20
30
40
50
60
70
80
90
100
2023 2024 2025 2026 2027 2028 2029 2030
(in
$
B
ill
io
ns
)
Source: Grand View Research Source: Global Data
Summary
Jamie Beggs
Senior Vice President and Chief Financial Officer
Avient Corporation 72
OUR SUSTAINABILITY REPORT
Avient Corporation 73
Avient Corporation 74
2030 SUSTAINABILITY GOALS
Avient Corporation 75
PERFORMANCE AND RECOGNITION
1
2
5
ESG Ratings Performance
ESG Awards and Certifications
top 13%
94th
percentile
Avient Corporation 76
SUSTAINABILITY INNOVATION AWARDS
Ultra-Low Carbon
Footprint TPE
Innovation Award, Finalist:
Plastics Industry Association
PCR Colorants + Additives
Sustainable Packaging Innovation,
Finalist: U.S.
Plastics Pact
Post-Consumer Recycle (PCR)
Color Predictive Tool
Innovation Award, Winner:
Plastics Industry Association
Product Technology Innovation, Winner:
Plastics Recycling Awards Europe 2023
Additive for
Enhanced Recycling
Innovation Award, Finalist:
Plastics Industry Association
Product Technology Innovation, Finalist:
Plastics Recycling Awards Europe 2023
Service Innovation
Enables Quality Recycle
Product Innovation
Enables PCR Claims + Low CO2
Product Innovation
Protects Quality Recycle
…are Growing at Twice the Rate as
Conventional Products
Sustainably-Branded Products…
Consumers
Are demanding
recyclability and eco-
conscious products
Governments
Are mandating changes
through legislation, taxes,
and regional accords
STAKEHOLDER INFLUENCE DRIVES DEMAND
For Sustainable Products From Sustainable Companies
Brand Owners
Have committed to ambitious
goals to achieve
sustainability metrics
Avient Corporation 77
Avient Corporation 78
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
50
90
2022 2030
Medical Plastics
Market Size
(in $Billions)
2020 2030
12%
CA
GR
3%
CA
GR
Recycled
Plastics
Virgin
Plastics
Growing Demand for
Recycled Content
Avient Sustainable
Solutions
11
%
CA
GR
8%
CA
GR
Sources: McKinsey, Bloomberg, Grand View Research
Avient Corporation 79
Increasing the use
of recycled content
Reducing weight to
lower fuel consumption
2022 SALESDESCRIPTION
$340M
$310M
$525M
OUTCOMES
Enabling customers to
advance the circular economy
Shrinking carbon footprint
and decreasing emissions
Making our planet a better
place for all
Using fewer natural resources;
protecting human life
$1,175MTOTAL SALES
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
AVIENT IS WELL-POSITIONED
A Clean House
Avient holds leading ratings on
ESG matters of importance to
customers, countries, and
key stakeholders
Leading Portfolio
Our formulation expertise and materials
are meeting the unique sustainability
needs of our customers around the world
in endless applications
8-12% Long-Term Growth RateAvient’s Sustainable Solutions
Investing in Innovation
85% of our opportunity funnel is
directed at sustainable solutions
addressing unmet customer needs
Avient Corporation 80
Avient Corporation 81
ADJUSTED EBITDA MARGIN EXPANSION
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to be
driven by key growth drivers, with
sustainable solutions playing a
meaningful role
5.4%
11.5%
16.0%
17.3%
20% 20.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
Community Service
7x Safer
than Industry Average
World-Class Safety
Leadership Development
Over $19 million
raised since 2007
Diversity & Inclusion
PEOPLE AND CULTURE
Avient Corporation 82
Avient Corporation 83
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
LONG-TERM OBJECTIVES
Avient Corporation 84
Wrap Up and Q + A
Bob Patterson
Chairman, President, and Chief Executive Officer
Avient Corporation 85
Investor Deck_9_19_23 v4_WEBSITE_GAAP.pdf
2023 SR Non-GAAP Rec v3
https://www.avient.com/sites/default/files/2021-12/Chemically Resistant Materials Whitepaper.pdf
In this study, Avient’s Trilliant™ HC8900 and Edgetek™
ET8900 thermoplastics were tested alongside
competitive materials used for various medical
and consumer device enclosures.
This study
included exposing the materials to leading medical-
grade disinfectants, as well as common household
disinfectants/cleaners.
4© 2021 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
MATERIALS AND METHODS
The following commercially available healthcare disinfectants were utilized for ESCR testing: CaviCide™,
Super Sani-Cloth®, SporGon™, Vesphere® IIse, and Virex® TB.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
then a fully-
owned subsidiary of Dow Chemical).
Prior to joining Dow, she
was Corporate Vice President and Global General Manager, Ion
Exchange Resins at the Rohm and Haas Company (now a fullyff -
owned subsidiary of Dow), where she spent more than 20
years serving in numerous senior roles with increasing
responsibilities.
Global CARE Insurance (Critical Care Air Rescue and Evacuation), which provides supplemental
medical services and medical transportation related to business travel, is also provided to all Named Executive
Offiff cers.
https://www.avient.com/sites/default/files/resources/POL%2520KeyBanc%2520IR%2520Presentation%2520w%2520non-GAAP%252009%252010%25202013.pdf
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.8
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM for taxes on resin gain
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Universal_Polyamide_Overmold_Thermoplastic_Elastomer.pdf
Molding condition:
Barrel temperature (from feed and nozzle) C (F):182, 249, 260, 260 (360, 480, 500, 500F)
Injection speed: 5.08 mm/min
TPE thickness: 1.5 mm.